135 related articles for article (PubMed ID: 30433841)
21. A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.
Ngabo F; Levin A; Wang SA; Gatera M; Rugambwa C; Kayonga C; Donnen P; Lepage P; Hutubessy R
Vaccine; 2015 Dec; 33(51):7357-7363. PubMed ID: 26519548
[TBL] [Abstract][Full Text] [Related]
22. Very long survival in pediatric cancer between 1944 and 1993.
Zhao G; Boysen CD; Brown EF; Hassanein KM; Holmes FF; Holmes GE
Chin Med J (Engl); 1999 Jul; 112(7):615-9. PubMed ID: 11601255
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the baseline survival outcomes of the "six Global Initiative for Childhood Cancer index cancers" in Africa.
van Heerden J; Balagadde-Kambugu J; Angom R; Lusobya RC; Chantada G; Desjardins L; Fabian ID; Israels T; Paintsil V; Hessissen L; Diouf MN; Elayadi M; Turner SD; Kouya F; Geel JA
Pediatr Hematol Oncol; 2023 Apr; 40(3):203-223. PubMed ID: 36369884
[TBL] [Abstract][Full Text] [Related]
24. Wilms tumor imaging: patient costs and protocol compliance.
Carrico CW; Cohen MD; Zerin JM; Weetman R
Radiology; 1997 Sep; 204(3):627-33. PubMed ID: 9280236
[TBL] [Abstract][Full Text] [Related]
25. Patient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda.
Park PH; Davey S; Fehr AE; Butonzi J; Shyirambere C; Hategekimana V; Bigirimana JB; Borg R; Uwizeye R; Tapela N; Shulman LN; Randall T; Mpanumusingo E; Mpunga T
J Glob Oncol; 2018 Dec; 4():1-11. PubMed ID: 30582433
[TBL] [Abstract][Full Text] [Related]
26. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
Zekri W; Yacoub DM; Ibrahim A; Madney Y
J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372
[TBL] [Abstract][Full Text] [Related]
27. Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India.
Parambil BC; Narula G; Prasad M; Shah S; Shet T; Shridhar E; Khanna N; Laskar S; Gujral S; Sankaran H; Banavali S
Pediatr Blood Cancer; 2020 Feb; 67(2):e28058. PubMed ID: 31724304
[TBL] [Abstract][Full Text] [Related]
28. Challenge of pediatric oncology in Africa.
Hadley LG; Rouma BS; Saad-Eldin Y
Semin Pediatr Surg; 2012 May; 21(2):136-41. PubMed ID: 22475119
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and associated factors of depression and anxiety among patients with cancer seeking treatment at the Butaro Cancer Center of Excellence in Rwanda.
Habimana S; Biracyaza E; Mpunga T; Nsabimana E; Kayitesi F; Nzamwita P; Jansen S
Front Public Health; 2023; 11():972360. PubMed ID: 36875374
[TBL] [Abstract][Full Text] [Related]
30. The Collaborative Wilms Tumour Africa Project; baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan Africa.
Paintsil V; David H; Kambugu J; Renner L; Kouya F; Eden T; Hesseling P; Molyneux E; Israels T
Eur J Cancer; 2015 Jan; 51(1):84-91. PubMed ID: 25465189
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert
Erfani P; Gaga E; Hakizimana E; Kayitare E; Mugunga JC; Shyirambere C; Milner DA; Shulman LN; Ruhangaza D; Fadelu T
Bull World Health Organ; 2023 Jan; 101(1):10-19. PubMed ID: 36593782
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
Vijenthira A; Chan K; Cheung MC; Prica A
Lancet Haematol; 2020 Feb; 7(2):e146-e156. PubMed ID: 31948928
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012 to 2018.
Mpunga T; Clifford GM; Morgan EA; Milner DA; de Martel C; Munyanshongore C; Muvugabigwi G; Combes JD
Int J Cancer; 2022 Mar; 150(5):753-760. PubMed ID: 34626122
[TBL] [Abstract][Full Text] [Related]
34. Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.
Biasoli I; Castro N; Delamain M; Silveira T; Farley J; Pinto Simões B; Solza C; Praxedes M; Baiocchi O; Gaiolla R; Franceschi F; Bonamin Sola C; Boquimpani C; Clementino N; Fleury Perini G; Pagnano K; Steffenello G; Tabacof J; de Freitas Colli G; Soares A; de Souza C; Chiattone CS; Raggio Luiz R; Milito C; Morais JC; Spector N
Int J Cancer; 2018 Mar; 142(5):883-890. PubMed ID: 29023692
[TBL] [Abstract][Full Text] [Related]
35. Pregnancy-associated breast cancer in rural Rwanda: the experience of the Butaro Cancer Center of Excellence.
Dusengimana JMV; Hategekimana V; Borg R; Hedt-Gauthier B; Gupta N; Troyan S; Shulman LN; Nzayisenga I; Fadelu T; Mpunga T; Pace LE
BMC Cancer; 2018 Jun; 18(1):634. PubMed ID: 29866062
[TBL] [Abstract][Full Text] [Related]
36. Initiating Childhood Cancer Treatment in Rural Rwanda: A Partnership-Based Approach.
Stulac S; Mark Munyaneza RB; Chai J; Bigirimana JB; Nyishime M; Tapela N; Chaffee S; Lehmann L; Shulman LN
Pediatr Blood Cancer; 2016 May; 63(5):813-7. PubMed ID: 26785111
[TBL] [Abstract][Full Text] [Related]
37. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
Elayadi M; Magdy S; Khalil E; Zekri W
J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
[TBL] [Abstract][Full Text] [Related]
38. Decreasing Histology Turnaround Time Through Stepwise Innovation and Capacity Building in Rwanda.
Muvugabigwi G; Nshimiyimana I; Greenberg L; Hakizimana E; Ruhangaza D; Benewe O; Bhai K; Pepoon JR; Fehr AE; Park PH; Butonzi J; Shyirambere C; Manirakiza A; Rusangwa C; Milner D; Mpunga T; Shulman LN
J Glob Oncol; 2018 Sep; 4():1-6. PubMed ID: 30241136
[TBL] [Abstract][Full Text] [Related]
39. Benign and Malignant Breast Disease at Rwanda's First Public Cancer Referral Center.
Pace LE; Dusengimana JM; Hategekimana V; Habineza H; Bigirimana JB; Tapela N; Mutumbira C; Mpanumusingo E; Brock JE; Meserve E; Uwumugambi A; Dillon D; Keating NL; Shulman LN; Mpunga T
Oncologist; 2016 May; 21(5):571-5. PubMed ID: 27009935
[TBL] [Abstract][Full Text] [Related]
40. What will it cost to prevent violence against women and girls in low- and middle-income countries? Evidence from Ghana, Kenya, Pakistan, Rwanda, South Africa and Zambia.
Torres-Rueda S; Ferrari G; Orangi S; Hitimana R; Daviaud E; Tawiah T; Prah RKD; Karmaliani R; Kapapa E; Barasa E; Jewkes R; Vassall A
Health Policy Plan; 2020 Aug; 35(7):855-866. PubMed ID: 32556173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
